InspireMD Inc
InspireMD Inc (NSPR) Covered Calls
As of September 21, 2026, NSPR has 1 covered call opportunities in the coming three months. Return ranges from 240.0 to 240.0% until expiration. Annualized return ranges from 580.1 to 580.1%. The nearest expiration is February 19, 2027. Maximum potential profit is $180.
Read more
Running NSPR covered calls helps you generate consistent income from InspireMD Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on InspireMD Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best NSPR covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if NSPR stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling NSPR covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given InspireMD Inc covered call is worth writing.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications.
The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
Income-focused investors, long-term NSPR holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling NSPR covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best InspireMD Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile3.97% Subdued
- Market cap (M$)35
- 52 weeks high-70.70%
- 52 weeks low19.05%
- Analyst recommendationStrong Buy
1.00 - Target price$3.33
335.92% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-10
- P/E—
- Future P/E—
- EPS (ttm)-0.65
- EPS growth next 5 years—
As of September 21, 2026
| 2027-02-19 | 151 | 2.50 | 233.33 | 0.05 | 0.15 | 180.00 | 240.00 | 580.13 | -6.67 | +0.30 | 81 | 0.10 |
As of September 21, 2026
Sell covered calls with the data behind you
Find the best NSPR covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→